Photopharmacology – Photolabile caged compounds

A recently initiated project based on the controlled activity of drugs using light.

The rationale is to obtain an inactive compound that becomes active when it is irradiated locally in a tissue or specific area of the body with light with an specific wavelenght to control the dose and site of action of the drug.

Excellent results have been obtained in a proof of concept test with an animal model of pain. This technology can be applied to the treatment of chronic diseases that require precise control of the activity of the drug.